CA 125 is an antigenic determinant on a high-molecular-weight glycoprotein recognized by
a monoclonal antibody which was raised using an ovarian cancer cell line as an …

OBJECTIVE: The purpose of this study was to establish normal ranges for human epididymis
protein 4 (HE4) serum levels in healthy women. STUDY DESIGN: HE4 levels were …

OBJECTIVE: The human epididymis protein 4 (HE4) is a novel biomarker for ovarian cancer.
This study measured the HE4 and CA125 levels in women with benign gynecological …

Objectives: Recent studies have shown that the high affinity of mesothelin-CA125 interaction
might cause intracavitary tumor metastasis. We examined the clinicopathologic significance …

BACKGROUND: Mesothelin, a tumor differentiation antigen highly expressed in
mesothelioma and ovarian cancer, is the receptor for CA-125 (MUC 16) and this interaction …

CA 125 is an antigenic determinant on a high molecular weight glycoprotein. A monoclonal
antibody has been produced which recognizes this, and allows us to measure the …

Plasma levels of tumor markers (CEA, TPA, CA 15.3, CA 125, Α-fetoprotein) for 50 patients
with hypertensive disorders of pregnancy were compared with those of 50 healthy women …

Objective To further elucidate the origin of the physiological CA-125 amounts that lead to
cyclic changes in CA-125 serum levels in normally menstruating women. Design Fifty-three …

Background: Ovarian cancer remains a major worldwide health care issue due to the lack of
satisfactory diagnostic methods for early detection of the disease. Prior studies on the role of …

OBJECTIVES: To determine the efficiency of different tumor markers (CA-125,
carcinoembrionic antigen, CA-15.3, CA-19.9) and insulin-like growth factor I (IGF-I) …